[Tumor markers in malignant lymphoma].

¹Dept. of Hematology and Cell Therapy, Aichi Cancer Center, Central Hospital, Nagoya, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy

|June 30, 2005

Summary

Malignant lymphoma diagnosis lacks specific tumor markers, but cell surface markers and karyotypic analysis aid diagnosis with clinical data. Prognostic indices like IPI, FLIPI, and IPS guide treatment strategies for lymphoma subtypes.

Area of Science:

Hematology
Oncology
Clinical Pathology

Context:

Malignant lymphoma diagnosis currently lacks a single, highly sensitive and specific tumor marker.
Existing diagnostic approaches rely on integrating various markers with clinical and pathological data.
Prognostic scoring systems are crucial for tailoring treatment strategies in lymphoma management.

Purpose:

To elucidate the significance of various tumor markers in the diagnosis and prognosis of malignant lymphoma.
To review the utility of cell surface markers, karyotypic analysis, and prognostic indices (IPI, FLIPI, IPS) in lymphoma.
To discuss the role of non-specific markers like soluble interleukin-2 receptor (sIL-2 R) in evaluating therapeutic efficacy.

Summary:

While no definitive tumor marker exists for malignant lymphoma, cell surface markers and karyotypic analysis offer diagnostic value when combined with clinical information.
Prognostic indices such as the International Prognostic Index (IPI), Follicular Lymphoma International Prognostic Index (FLIPI), and International Prognostic Score (IPS) are essential for predicting outcomes and guiding therapeutic decisions in aggressive non-Hodgkin's lymphoma (NHL), follicular lymphoma, and Hodgkin's lymphoma.
Non-specific markers, including soluble interleukin-2 receptor (sIL-2 R), are employed to monitor treatment response.

Impact:

Improved understanding of tumor marker utility can enhance diagnostic accuracy in malignant lymphoma.
Effective application of prognostic indices facilitates personalized therapeutic strategies, potentially improving patient outcomes.
Monitoring non-specific markers aids in timely assessment of treatment effectiveness and adjustments.

Related Experiment Videos

[Tumor markers in malignant lymphoma].

Related Concept Videos

[A literature review of support skills used by occupational health nurses in facilitating return to work for employees with mental health issues].

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Draft of the self-regulated learning scale items for learning nursing skills based on the cyclical phase model and evaluation of their content validity.

Activity of a Medical Relief Team from Shizuoka Hospital that was Dispatched to the Noto Peninsula Earthquake in Reiwa 6 (2024).

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.

R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

[BRAF-Mutant Solid Tumor].

A Novel 7 Sialylation-Related LncRNA Signature as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

Prediction of meningioma shrinkage after cyproterone acetate cessation.

Risk of colorectal cancer incidence and mortality after removals of polyps: a cohort study using the UK Biobank.

<i>In vivo</i> assessment of melanoma based on photoacoustic absorption and viscoelasticity imaging.

High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance.

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study.

Related Experiment Videos

[Tumor markers in malignant lymphoma].

Area of Science:

Context:

Purpose:

Summary:

Impact:

Related Concept Videos

Related Articles